Tim Andrews is recovering well after receiving a kidney from a genetically modified pig. Massachusetts General Hospital is ...

New Hampshire native Tim Andrews was quite happy to spend his 67th birthday on Wednesday at Mass General Hospital (MGH). On ...

Genetically modified pigs with human-compatible organs offer a potential solution to the organ shortage crisis, with ongoing ...

After years of research into xenotransplantation, the field is at a turning point—yet risks and ethical issues remain ...

Last year, a 62-year-old man lived with a pig kidney for almost two months before ... allowed clinical trials for the transplantation of pig kidneys. The biotech company United Therapeutics ...

The U.S. Food and Drug Administration recently approved the first-ever clinical trial of the transplantation of a nonhuman animal organ—a genetically modified pig kidney—into living human ...

The xenotransplantation approach seeks to alleviate shortage of human organs, and could potentially provide a lifeline to ...

Tim Andrews had not felt great in a long time, but he says all that changed when he became the second patient at Massachusetts General Hospital to undergo a pig kidney transplant. "During the dialysis ...

How have the first patients fared after receiving organ transplants from genetically modified pigs? Roni Caryn Rabin, a health reporter on the Science desk of The New York Times, looks at the results ...

Even if the trials show positive results, widespread adoption of pig kidney transplants may take several years due to regulatory approvals, cost evaluations, and long-term safety assessments.

MGH nephrologist Leonardo Riella and surgeon Tatsuo Kawai talk with reporters about Massachusetts General Hospital's second transplant of a genetically edited pig kidney into a living human recipient.